Objective response to radiation therapy and long-term survival of patients with WHO grade II astrocytic gliomas with known LOH 1p/19q status

Strahlentherapie und Onkologie

Volumn 183, Issue 9, 2007, Pages 517-522

  Fathi, Ali Reza ^a   Vassella, Erik ^b   Arnold, Marlene ^b   Curschmann, Jürgen ^a   Reinert, Michael ^a   Vajtai, Istvan ^b   Weis, Joachim ^b,c   Deiana, Gianluca ^a   Mariani, Luigi ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Glioma; LOH; MRI; Radiation therapy; Tumor response

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ASTROCYTOMA; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; CRANIAL IRRADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LOSS OF HETEROZYGOSITY; MAGNETIC RESONANCE IMAGING; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS; SURVIVAL ANALYSIS; SURVIVORS;

EID: 34548331506     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1673-6     Document Type: Article

References (26)

1. Bauman GS, Ino Y, Ueki K, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000;48:825-30.
2. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-9.
3. Combs SE, Gutwein S, Thilmann C, et al. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlenther Onkol 2005;181:768-73.
4. Fisher BJ, Bauman GS, Leighton CE, et al. Low-grade gliomas in children: tumour volume response to radiation. Neurosurg Focus 1998;4:e5.
5. Fuss M, Wenz F, Scholdei R, et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 2000;48:53-8.
6. Grabenbauer GG, Roedel CM, Paulus W, et al. Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy. Strahlenther Onkol 2000;176:259-64.
7. Heesters M, Molenaar W, Go GK. Radiotherapy in supratentorial gliomas. A study of 821 cases. Strahlenther Onkol 2003;179:606-14.
8. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004;22:3133-8.
9. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002;52:316-24.
10. Kleihues P, Davis RL, Ohgaki H, et al. Diffuse astrocytoma. In: Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000:22-6.
11. Kocher M, Kunze S, Eich HT, et al. Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma. Strahlenther Onkol 2005;181:157-63.
12. Kortmann RD, Jeremic B, Weller M, et al. Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma? Strahlenther Onkol 2004;180:408-18.
13. Macdonald DR, Cascino TL, Schold SC Jr, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-80.
14. Mariani L, Deiana G, Vassella E, et al. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol 2006; 24:4758-63.
15. Mariani L, Siegenthaler P, Guzman R, et al. The impact of tumour volume and surgery on the outcome of adults with supratentorial WHO grade II astrocytomas and oligoastrocytomas. Acta Neurochir (Wien) 2004;146:441-8.
16. Nowak Sadzikowska J, Glinski B, Szpytma T, et al. Postoperative irradiation of incompletely excised gemistocytic astrocytomas. Clinical outcome and prognostic factors. Strahlenther Onkol 2005;181:246-50.
17. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64:479-89.
18. Okamoto Y, Di Patre PL, Burkhard C, et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol (Berl) 2004;108:49-56.
19. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076-84.
20. Schueller P, Micke O, Palkovic S, et al. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas. Strahlenther Onkol 2005;181:500-6.
21. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-76.
22. Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999;18:4144-52.
23. Stupp R, Hegi ME, van den Bent MJ, et al. Changing paradigms - an update on the multidisciplinary management of malignant glioma. Oncologist 2006;11:165-80.
24. Stupp R, Janzer RC, Hegi ME, et al. Prognostic factors for low-grade gliomas. Semin Oncol 2003;30:23-8.
25. Van den Bent MJ, Afra D, De Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005;366:985-90.
26. Van den Bent M, Chinot OL, Cairncross JG. Recent developments in the molecular characterization and treatment of oligodendroglial tumours. Neurooncology 2003;5:128-38.